Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Randomized, Double-Blind, Phase 3 Study of Efficacy and Safety of ABP 501 Compared with Adalimumab in Subjects with Moderate to Severe Rheumatoid Arthritis Cohen, S. B., Genovese, M. C., Choy, E. H., Perez-Ruiz, F., Pablos, J. L., Zhang, N., Kaur, P. WILEY-BLACKWELL. 2015
View details for Web of Science ID 000370860203460